<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160731029133N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-01-30</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation the effect of complementary treatment with pistacia atlantica mouthwash on chemotherapy-induced mucositis</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation the effect of complementary treatment with pistacia atlantica mouthwash on chemotherapy-induced mucositis (a double blind randomized placebo controlled clinical trial)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-01-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/23502</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: All the members of both groups have to use MAGIC mouthwash as the basic treatment.This mouthwash consists of: Aluminum-magnesium suspension 200 ml,Diphenhydramine Syrup 50 ml,One Lidocaine carpule,One Dexamethasone ampule,and a bottle of Nystatine.All the members of both groups have to gargle 10 ml of this mouthwash 30 seconds,3 times a day for 7 days, Randomization description: We use Block Randomization with individual units in this study and we use sealed envelopes as randomization tool, Blinding description: This is a double blind study.actually the researcher and the participates aren't aware of the grouping randomization process.In order to blind the researcher,instead of the researcher,one of the hospital doctors will put each participate into one of two groups randomly; and in order to blind participates we try to make the mouthwash and the placebo taste the same and prescribe in similar bottles.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Condition 1: chemotherapy-induced mucositis. Condition 2: Xerostomia.</hc_freetext>
      <i_freetext>Intervention 1: The members of the experimental group have to use Pistacia Atlantica mouthwash in addition to that basic treatment.This mouthwsh consists of: Humectant 5-20%(Glycerine-Sorbitol- propylene glycol),Surfactant 5%(Tween80 and sodium lauryl sulfate),a small am. Intervention 2: The members of the control group have to use placebo in addition to basic treatment,to eliminate mental effects.(However they shoudn't know that this mouthwash is just a placebo.)&#13;
Placebo consists of flavoring agents and water.the members of the control .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All datas will be published after blinding

When:
2 m after publishing the results

To whom:
researchers working in scientific centers

Conditions:
datas can be use for furture analysis

Where to obtain:
zanjan dental school

How to obtain:
1- written request ti research center
2- evaluation in reasearch councile.
3- 1 month

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Neda Gholami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zanjan Faculty of Dentistry, Shahrak Karmandan</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4513956112</zip>
        <telephone>+98 24 3347 1118</telephone>
        <email>dr.gholami.n@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Neda Gholami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zanjan Faculty of Dentistry, Shahrak Karmandan</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4513956112</zip>
        <telephone>+98 24 3347 1118</telephone>
        <email>dr.gholami.n@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1-Existence of chemotherapy-induced mucositis.                           2-Participates must be at least 18 years old.                                   3-Not existence of serious dental problems or traumatic teeth or sharp-pointed cusps or fillings.                                                         4-Not using of traumatic dentures.                                                   5-Not using of anti-inflammatory agents or other mouthwashes during the study.                                                                                 6-Absence of other systemic disease</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1-Patients' inability to do the instructions of the protocol of the study.                                                                                                   2-Patients' death because of not responding to the cancer treatment.                                                                                            3-Complementary treatments such as radiotherapy.                      4-The history of allergy to pistacia atlantica.                                   5-The history of usage of cigarette,narcotics and alcohol.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K12.3</hc_code>
      <hc_code>K11.7</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Oral mucositis (ulcerative)</hc_keyword>
      <hc_keyword>Disturbances of salivary secretion</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The members of the experimental group have to use Pistacia Atlantica mouthwash in addition to that basic treatment.This mouthwsh consists of: Humectant 5-20%(Glycerine-Sorbitol- propylene glycol),Surfactant 5%(Tween80 and sodium lauryl sulfate),a small am</i_keyword>
      <i_keyword>The members of the control group have to use placebo in addition to basic treatment,to eliminate mental effects.(However they shoudn't know that this mouthwash is just a placebo.)&#13;
Placebo consists of flavoring agents and water.the members of the control </i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of oral mucositis. Timepoint: Before intervention, 3 days after beginning of the intervention, 7 days after beginning of the intervention(the last day of the intervention). Method of measurement: WHO scoring system.</prim_outcome>
      <prim_outcome>Severity of xerostomia. Timepoint: Before intervention, 3 days after beginning of the intervention, 7 days after beginning of the intervention(the last day of the intervention). Method of measurement: Lickert's method.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-08-22</approval_date>
        <contact_name>Ethics committee of Zanjan University of Medical Sciences</contact_name>
        <contact_address>Zanjan University of Medical Sciences, Azadi Square Zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
